首页> 外文学位 >Biopolymer-based ocular drug delivery systems.
【24h】

Biopolymer-based ocular drug delivery systems.

机译:基于生物聚合物的眼用药物输送系统。

获取原文
获取原文并翻译 | 示例

摘要

A major problem in ocular therapeutics is the attainment of an optimal drug concentration at the site of action. Because of the specific structure of the eye, the treatment of ocular diseases is often a drug delivery problem. This dissertation represents a systematic study of molecular structure-property-performance relationship of chemically modified starch-based ocular drug delivery systems.;The specific polymers investigated were Dihydroxyl Starch (DHS) and DHS Esters including acetates and propionates. The DHS was prepared through a two-step method. Starch was first oxidized by NaIO4 to form Dialdehyde Starch (DAS) and DAS was reduced to form the corresponding hydroxyls with NaBH4. After this modification, polymers with increased solubility in water were obtained. By varying the ratio between starch and oxidant in the first step, the content of Dialdehyde groups was controlled; thereafter 20DHS, 60DHS, and 100DHS were prepared. Among them, 100DHS was further esterified to obtain DHS acetates (DHSA) and DHS Propionates (DHSP). During esterification, the degree of substitution (DS) of DHSA and DHSP was controlled and in this work DHSA and DHSP with DS equal to 0.1 and 0.4 were prepared.;The specific aspects investigated in this research were surface property, mucoadhesion, rheological behavior, controlled drug release, and their effects on ocular drug delivery systems' performance in animal tests. (1) Surface property. Previous work was focused on lowering surface tension (ST) to help spreading. In this work, we took the Weipeng Liu ST's effect on both spreading and adhesion into account and suggested an ideal ST should be moderately lower than that of the cornea. (2) Mucoadhesion. A strong adhesion with mucus in the eye helps a drug delivery system to achieve a prolonged retention time and form a strengthened network that sustains the release of drug. In this work, the mucoadhesion of synthesized polymers was studied through a typical rheological approach. (3) Rheological properties. Flow properties were thoroughly studied by other researchers. However, it is rare for ophthalmic solutions to undergo only steady state shear rate in situ. Thus, it was necessary to investigate their viscoelastic properties as well, which were omitted by previous researchers. Therefore, in this work both steady shear and dynamic behaviors of synthesized polymers were studied to investigate their effects on ocular drug delivery systems. (4) Controlled drug release. The drug release profile is important for achievement of sustained drug release and they were studied with a standard USP dissolution method in this work. None of the four concepts we investigated is new and some of them have been introduced to the study of ocular drug delivery systems, however, no work has been done to study their effects systematically. As the first work of systematic study of biopolymer-based ocular drug delivery systems, we studied how these properties were affected by molecular structures, how they should be designed by engineering chemical structures accordingly, and how they affected the performance of ocular drug delivery systems, both theoretically and experimentally. The work described in this dissertation helps fill the knowledge gaps, which exist for the design of effective ocular drug delivery systems with modified starch.
机译:眼治疗的主要问题是在作用部位达到最佳药物浓度。由于眼睛的特殊结构,眼部疾病的治疗通常是药物输送的问题。本论文是对化学修饰淀粉基眼药水体系分子结构-性能-性能关系的系统研究。所研究的具体聚合物为二羟基淀粉(DHS)和DHS酯,包括乙酸盐和丙酸盐。 DHS是通过两步法制备的。淀粉首先被NaIO4氧化形成二醛淀粉(DAS),然后DAS与NaBH4还原形成相应的羟基。进行这种改性后,获得了在水中溶解度增加的聚合物。在第一步中,通过改变淀粉与氧化剂的比例来控制二醛基的含量。此后准备20DHS,60DHS和100DHS。其中,将100DHS进一步酯化以获得DHS乙酸酯(DHSA)和DHS丙酸酯(DHSP)。在酯化过程中,控制DHSA和DHSP的取代度(DS),并在本文中制备DS分别等于0.1和0.4的DHSA和DHSP .;本研究的具体方面包括表面性质,粘膜粘附性,流变行为,控制药物释放,以及它们在动物试验中对眼部药物传递系统性能的影响。 (1)表面性质。先前的工作重点是降低表面张力(ST)以帮助扩散。在这项工作中,我们考虑到了维蓬刘ST对散布和粘连的影响,并建议理想的ST应该比角膜的适度低。 (2)粘膜粘连。眼中与粘液的强粘附力有助于药物输送系统延长保留时间,并形成维持药物释放的强化网络。在这项工作中,通过典型的流变方法研究了合成聚合物的粘膜粘附性。 (3)流变性。其他研究人员对流动特性进行了彻底的研究。但是,眼药水很少仅在原位经历稳态剪切速率。因此,也有必要研究它们的粘弹性,而先前的研究人员则忽略了它们。因此,在这项工作中,研究了合成聚合物的稳态剪切和动态行为,以研究它们对眼药物递送系统的影响。 (4)控制药物释放。药物释放曲线对于实现药物的持续释放很重要,并且在这项工作中使用标准的USP溶出方法对其进行了研究。我们研究的四个概念中没有一个是新的,其中一些已被引入眼用药物输送系统的研究中,但是,还没有系统地研究它们的作用。作为对基于生物聚合物的眼用药物输送系统进行系统研究的第一项工作,我们研究了分子结构如何影响这些特性,应如何通过工程化学结构设计它们,以及它们如何影响眼用药物输送系统的性能,无论在理论上还是实验上。本论文所描述的工作有助于填补知识空白,对于设计具有改性淀粉的有效眼部药物递送系统而言,存在知识空白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号